We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
AB 1990 is a Trojan Horse packaged as a patient safety bill. APC is actively fighting it - here's how we're protecting compounders.
Dr. Marty Makary has resigned as FDA Commissioner, with Kyle Diamantas stepping in as acting commissioner. What does that mean for compounding?
An update on state legislation and changes impacting compounding pharmacies – May 8, 2026.
The House Agriculture Committee's FDA appropriations report contains several sections relevant to compounding – what to know.
Congressman Michael Rulli (R-OH) has introduced the Protecting Equal Access to Thyroid (PEAT) Act of 2026 – what it means for compounding.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
